Home About us Articles Multimedia Search Instructions Login 
5 years IF: 1.036 (® Thomson Reuters)
IF 2016: 1.064 (® Thomson Reuters)
Total Cites: 7140
Follow Us
Follow Us
  • Users Online: 4021
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment

Li Ming-Hui, Zhang Lu, Qu Xiao-Jing, Lu Yao, Shen Ge, Wu Shu-Ling, Chang Min, Liu Ru-Yu, Hu Lei-Ping, Li Zhen-Zhen, Hua Wen-Hao, Song Shu-Jing, Xie Yao

Year : 2017| Volume: 130| Issue : 5 | Page no: 559-565

   This article has been cited by
1 A meta-analysis of the antiviral activity of the HBV-specific immunotherapeutic TG1050 confirms its value over a wide range of HBsAg levels in a persistent HBV pre-clinical model
Roland Kratzer,Benoît Sansas,Karine Lélu,Alexei Evlachev,Doris Schmitt,Nathalie Silvestre,Geneviève Inchauspé,Perrine Martin
Human Vaccines & Immunotherapeutics. 2018; : 00
[Pubmed]  [Google Scholar] [DOI]
2 Impact of deletions and mutations in Hepatitis B virus envelope proteins on serological profile and clinical evolution
Brice Malve,Marine Eschlimann,Shaunagh Galgey,Honorine Fenaux,Fabien Zoulim,François Goehringer,Christian Rabaud,Thierry May,Hélène Jeulin,Evelyne Schvoerer
Virus Research. 2017; 238: 141
[Pubmed]  [Google Scholar] [DOI]


Read this article